Alex Gorsky, CEO of Joulsen Group, said that people may need annual vaccination against pneumonia.
The Wuhan pneumonia (COVID-19) vaccine has been introduced in various countries, and people are hoping that the Epidemic will end after widespread vaccination, and they think that one vaccination is enough.
Unfortunately, as the virus spreads, it can also mutate. Unfortunately, as the virus spreads, it also mutates,” Johnson & Johnson CEO Gosky told the hosts. “Every Time the virus mutates, it’s almost like a phone ringing to tell us that there’s another variant of the virus that’s going to increase its ability to break through the antibodies and make the treatment and the vaccine respond differently as well.
Jolson said last week that they have applied to the U.S. Food and Drug Administration (FDA) for emergency use authorization and will also apply to European regulators in the coming weeks; Gorski said the company’s priority now is to work with the FDA to obtain U.S. authorization.
Gosky revealed that Joulsen is moving full speed ahead with vaccine production, adding that they are very confident they can meet their goal of delivering 100 million doses of the vaccine to the U.S. by the end of June. Currently, the Joulsen vaccine requires only a single dose, and Gosky said the company will continue to research another vaccine that requires two doses and expects to have data from clinical trials in the second half of the year.
The Woo Lung vaccine may need to be administered annually, just like the flu vaccine. (Photo shows Americans getting vaccinated).
Recent Comments